Gland Pharma Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023-04 to 2024-03🗂️ Report periods on file: 2023-04 to 2024-03, 2022-04 to 2023-03

In its 2023-04 to 2024-03 reporting, Gland Pharma Limited disclosed greenhouse gas emissions of 96.9K metric tonnes of CO2 equivalent (Scope 1 and 2). By scope: Scope 1: 15.7K metric tonnes of CO2 equivalent; Scope 2: 81.2K metric tonnes of CO2 equivalent. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
96.9K metric tonnes of CO2 equivalent (Scope 1 and 2)
2023-04 to 2024-03
⚡
Renewable Energy
3%
of total energy
💧
Water Usage
541.0K kilolitres
2023-04 to 2024-03
♻️
Waste
2.0K metric tonnes
2023-04 to 2024-03

📊 Emissions by Scope (2023-04 to 2024-03)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).15.7K metric tonnes of CO2 equivalent
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.81.2K metric tonnes of CO2 equivalent

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2023-04 to 2024-0396.9K metric tonnes of CO2 equivalent (Scope 1 and 2)
2022-04 to 2023-0392.6K tCO2e (Scope 1 & 2)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🌱 ESG Focus Areas

Occupational health and safetyCommunity EngagementRegulatory CompliancePromoting DiversityCultural IntegrationESG Factors

⚠️ Challenges & Risks +

  • Occupational health and safety risks.
  • Frequent and intricate regulatory changes.
  • ESG Factors

📋 Report Information

Reporting Period: 2023-04 to 2024-03